Your browser doesn't support javascript.
loading
Research progress on anti-inflammatory effects of plant-derived cannabinoid type 2 receptor modulators / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 6294-6306, 2023.
Artigo em Chinês | WPRIM | ID: wpr-1008828
ABSTRACT
Excessive and persistent inflammatory responses are a potential pathological condition that can lead to diseases of various systems, including nervous, respiratory, digestive, circulatory, and endocrine systems. Cannabinoid type 2 receptor(CB2R) belongs to the G protein-coupled receptor family and is widely distributed in immune cells, peripheral tissues, and the central nervous system. It plays a role in inflammatory responses under various pathological conditions. The down-regulation of CB2R activity is an important marker of inflammation and and CB2R modulators have been shown to have anti-inflammatory effects. This study explored the relationship between CB2R and inflammatory responses, delved into its regulatory mechanisms in inflammatory diseases, and summarized the research progress on CB2R modulators from plants other than cannabis, including plant extracts and monomeric compounds, in exerting anti-inflammatory effects. The aim is to provide new insights into the prevention and treatment of inflammatory diseases.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Canabinoides / Receptores de Canabinoides / Moduladores de Receptores de Canabinoides / Agonistas de Receptores de Canabinoides / Anti-Inflamatórios Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2023 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Canabinoides / Receptores de Canabinoides / Moduladores de Receptores de Canabinoides / Agonistas de Receptores de Canabinoides / Anti-Inflamatórios Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2023 Tipo de documento: Artigo